Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims

    July 2021 in “ Advances in Therapy ”
    Maryanne M. Senna, Justin Ko, Antonella Tosti, Emily Edson-Heredia, D Christian Fenske, Amy K Ellinwood, M. J. Rueda, Baojin Zhu, Brett King
    Image of study
    TLDR Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.
    This study examined 68,121 patients with Alopecia Areata (AA) using IBM MarketScan® Research Databases and found that 55.8% received treatment within 12 months of diagnosis, with topical steroids being the most common. The average patient age was 40.3 years, and 61.0% were female. Common comorbidities included hyperlipidemia (22.4%), hypertension (21.8%), and thyroid disorders (13.1%). The mean total healthcare costs were $11,241.21 for all causes and $419.12 for AA, with outpatient and prescription costs as the main contributors. The study highlighted a high comorbidity burden, significant healthcare costs, and a lack of effective treatment utilization for AA, indicating a need for better treatment options and understanding of the disease's long-term impact.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 1000+ results

      community My experience and a discourse on “DUPA”

      in Chat  46 upvotes 1 year ago
      How diffuse unpatterned alopecia (DUPA) is not an invitation to self-diagnose oneself with aggressive AGA and that seeking a specialized dermatologist may help people experiencing hair loss. Treatment options discussed include topical clobetasol propionate, oral minoxidil, and discontinuing finasteride.

      community Rare Non responder to Finasteride, Dutasteride, and oral minoxidil

      in Minoxidil  78 upvotes 8 months ago
      A user did not respond to finasteride, dutasteride, and oral minoxidil for hair loss after four years of treatment and is considering scalp micropigmentation (SMP). Other users suggest the hair loss pattern may indicate alopecia areata and recommend seeing a dermatologist.

      community Why is no one pointing out dandruff as the number 1 evidence/symptom of MPB?

      in Chat  55 upvotes 1 year ago
      The post discusses the theory that persistent dandruff in areas prone to hair loss could be a sign of hair follicles dying due to DHT, indicating balding. The responses vary, with some users noting improvements in dandruff and hair loss with treatments like Dutasteride, while others experienced hair loss without dandruff.

      community *WOMEN* on Spironolactone - experiences?

       6 upvotes 9 years ago
      Hair loss treatments discussed: Minoxidil, Finasteride, RU58841, and Spironolactone. Woman with androgenetic alopecia and alopecia areata shares experience using Spironolactone.

    Related Research

    6 / 6 results